None
Quote | PDS Biotechnology Corporation (NYSE:PDSB)
Last: | $ |
---|---|
Change Percent: | -25.84% |
Open: | $1.30 |
Close: | $1.32 |
High: | $1.36 |
Low: | $1.29 |
Volume: | 1,249,860 |
Last Trade Date Time: | 02/12/2020 04:40:39 pm |
News | PDS Biotechnology Corporation (NYSE:PDSB)
2024-03-27 12:17:02 ET PDS Biotechnology Corporation (PDSB) Q4 2023 Earnings Conference Call March 27, 2024 08:00 a.m. ET Company Participants Dr. Frank Bedu-Addo - Chief Executive Officer Lars Boesgaard - Chief Financial Officer Dr. Kirk Shepard - Chief Medical ...
2024-03-27 07:31:30 ET More on PDS Biotechnology PDS Biotechnology: Advancement Of PDS0101 Continues With Expansion Data PDS Biotechnology: Promising Phase 2 With Cash Issues That Might Be Worth The Risk Seeking Alpha’s Quant Rating on PDS Biotechnology ...
Message Board Posts | PDS Biotechnology Corporation (NYSE:PDSB)
Subject | By | Source | When |
---|---|---|---|
PDSB excellent setup for next leg up... Very | l2 hunter | investorshub | 01/10/2023 2:36:31 PM |
Lol crypto not looking there right now too | starkd748 | investorshub | 01/04/2023 2:02:57 PM |
Need to look again...I haven't looked so nice | starkd748 | investorshub | 01/03/2023 9:23:42 PM |
Thoughts on efxusdt? Looks like inverse head and | Lwrnc2052 | investorshub | 01/03/2023 7:23:39 PM |
Got your pm ...Stochastic 90s on the weekly | starkd748 | investorshub | 01/03/2023 3:14:52 PM |
News, Short Squeeze, Breakout and More Instantly...
PDS Biotechnology Corporation Company Name:
PDSB Stock Symbol:
NYSE Market:
PDS Biotechnology Corporation Website:
Unique mechanism of action of the combination of PDS01ADC and Versamune ® results in 3-year survival of 75% and 75% overall response rate in advanced head and neck cancer trial As a result, Company to focus late-stage clinical strategy on triple combination of PDS01ADC,...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines ba...